Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-mesothelin (CRS-207) With or Without Nivolumab in Patients with Pancreatic Cancer

PURPOSE: Two studies in previously-treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells) with cyclophosphamide (Cy) and CRS-207 (live, attenuated Listeria monocytogenes e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Tsujikawa, Takahiro, Crocenzi, Todd, Durham, Jennifer N., Sugar, Elizabeth, Wu, Annie A., Onners, Beth, Nauroth, Julie M., Anders, Robert A., Fertig, Elana J., Laheru, Daniel A., Reiss, Kim A., Vonderheide, Robert H., Ko, Andrew H., Tempero, Margaret A., Fisher, George A., Considine, Michael, Danilova, Ludmila, Brockstedt, Dirk G., Coussens, Lisa M., Jaffee, Elizabeth M., Le, Dung T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727397/
https://ncbi.nlm.nih.gov/pubmed/32273276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3978
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados